These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12504786)

  • 21. Bimodal effects of chronically administered neurokinin B (NKB) on in vivo and in vitro cardiovascular responses in female rats.
    Yang J; Dhawan V; Morrish DW; Kaufman S
    Regul Pept; 2007 Oct; 143(1-3):136-42. PubMed ID: 17573134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered pressor responses to NE and ANG II during cyclosporin A administration to conscious rats.
    Textor SC; Smith-Powell L; Telles T
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H854-60. PubMed ID: 2316699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
    Dharmani M; Mustafa MR; Achike FI; Sim MK
    Eur J Pharmacol; 2007 Apr; 561(1-3):144-50. PubMed ID: 17320855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective potentiation of angiotensin-induced constriction of skeletal muscle resistance arteries by chronic elevations in dietary salt intake.
    Weber DS; Frisbee JC; Lombard JH
    Microvasc Res; 1999 May; 57(3):310-9. PubMed ID: 10329257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal vascular responsiveness to angiotensin II at an early stage of diabetes: interaction between intrarenal noradrenergic and renin-angiotensin systems.
    García VM; Monasterolo LA; Elías MM
    Acta Diabetol; 2003 Sep; 40(3):130-6. PubMed ID: 14605969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats.
    Cheng X; Cheng XS; Pang CC
    Eur J Pharmacol; 2003 Jun; 470(3):171-5. PubMed ID: 12798955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the haemodynamic actions of neuropeptide Y, angiotensin II and noradrenaline in anaesthetised cats.
    Corder R; Lowry PJ; Wilkinson SJ; Ramage AG
    Eur J Pharmacol; 1986 Feb; 121(1):25-30. PubMed ID: 3754217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta.
    Kobayashi T; Kaneda A; Kamata K
    Br J Pharmacol; 2003 Sep; 140(2):285-94. PubMed ID: 12970107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sodium, deoxycorticosterone and duration of hypertension on pressor responses in rats.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Physiol; 1982 Dec; 333():383-91. PubMed ID: 6763628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ruthenium-based nitric oxide scavenger, AMD6221, augments cardiovascular responsiveness to noradrenaline in rats with streptozotocin-induced diabetes.
    Hutchings SR; Song D; Fricker SP; Pang CC
    Eur J Pharmacol; 2005 Dec; 528(1-3):132-6. PubMed ID: 16310182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenergic nerves mediate the venoconstrictor response to PVN stimulation.
    Martin DS; Egland MC; Barnes LU; Vogel EM
    Brain Res; 2006 Mar; 1076(1):93-100. PubMed ID: 16473331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
    Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
    Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional role of brain AT1 and AT2 receptors in the central angiotensin II pressor response.
    Toney GM; Porter JP
    Brain Res; 1993 Feb; 603(1):57-63. PubMed ID: 8453478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
    Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine.
    Buckingham RE
    Br J Pharmacol; 1988 Mar; 93(3):541-52. PubMed ID: 3370388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous IGF-I receptor antisense reduces IGF-IR expression and diminishes pressor responses to angiotensin II in conscious normotensive rats.
    Nguyen TT; White PJ
    Br J Pharmacol; 2005 Dec; 146(7):935-41. PubMed ID: 16205725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short treatments of normotensive and hypertensive rats by angiotensin II and nitric oxide inhibitor induce an increase of noradrenaline sensitivity in isolated vena portae preparations.
    Datté JY; Gohlke P; Pees C; Ziegler A
    Pharmacol Res; 2000 Jun; 41(6):641-8. PubMed ID: 10816333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pressor sensitivities to vasopressin, angiotensin II, or methoxamine in diabetic rats.
    Hebden RA; Bennett T; Gardiner SM
    Am J Physiol; 1987 Nov; 253(5 Pt 2):R726-34. PubMed ID: 3318506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-1032, a novel specific phosphodiesterase type 5 inhibitor, increases venous compliance in anesthetized rats.
    Inoue H; Yano K; Ikeo T; Noto T; Kikkawa K
    Eur J Pharmacol; 2001 Jun; 422(1-3):109-14. PubMed ID: 11430921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.